Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000591149 | SCV000707227 | uncertain significance | not provided | 2017-03-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000591149 | SCV002175981 | likely benign | not provided | 2025-01-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002395533 | SCV002703477 | likely benign | Cardiovascular phenotype | 2022-04-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003330819 | SCV004038351 | likely benign | not specified | 2023-08-07 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004742530 | SCV005346185 | likely benign | ABCG8-related disorder | 2024-06-27 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |